ATE118549T1 - Verfahren zur synthese von ribonukleinsäure (rns). - Google Patents

Verfahren zur synthese von ribonukleinsäure (rns).

Info

Publication number
ATE118549T1
ATE118549T1 AT90201162T AT90201162T ATE118549T1 AT E118549 T1 ATE118549 T1 AT E118549T1 AT 90201162 T AT90201162 T AT 90201162T AT 90201162 T AT90201162 T AT 90201162T AT E118549 T1 ATE118549 T1 AT E118549T1
Authority
AT
Austria
Prior art keywords
synthesis
ribonucleic acid
rns
target sequence
sequence
Prior art date
Application number
AT90201162T
Other languages
English (en)
Inventor
Lawrence T Malek
Cheryl Davey
Peter Franklin Lens
Frits Wielaard
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE118549T1 publication Critical patent/ATE118549T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6865—Promoter-based amplification, e.g. nucleic acid sequence amplification [NASBA], self-sustained sequence replication [3SR] or transcription-based amplification system [TAS]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/705—Specific hybridization probes for herpetoviridae, e.g. herpes simplex, varicella zoster

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT90201162T 1989-05-10 1990-05-08 Verfahren zur synthese von ribonukleinsäure (rns). ATE118549T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8901172 1989-05-10

Publications (1)

Publication Number Publication Date
ATE118549T1 true ATE118549T1 (de) 1995-03-15

Family

ID=19854626

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90201162T ATE118549T1 (de) 1989-05-10 1990-05-08 Verfahren zur synthese von ribonukleinsäure (rns).

Country Status (13)

Country Link
US (1) US5466586A (de)
EP (1) EP0397269B1 (de)
JP (1) JP2839639B2 (de)
KR (1) KR0185376B1 (de)
AT (1) ATE118549T1 (de)
AU (1) AU641159B2 (de)
CA (1) CA2016358C (de)
DE (1) DE69016826T2 (de)
DK (1) DK0397269T3 (de)
ES (1) ES2070995T3 (de)
FI (1) FI102387B1 (de)
IE (1) IE66597B1 (de)
ZA (1) ZA903453B (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622820A (en) * 1988-03-10 1997-04-22 City Of Hope Method for amplification and detection of RNA and DNA sequences
GB8808892D0 (en) * 1988-04-15 1988-05-18 British Bio Technology Gene synthesis
US5130238A (en) * 1988-06-24 1992-07-14 Cangene Corporation Enhanced nucleic acid amplification process
US5169766A (en) * 1991-06-14 1992-12-08 Life Technologies, Inc. Amplification of nucleic acid molecules
JPH08500722A (ja) * 1992-01-29 1996-01-30 日立化成工業株式会社 ポリヌクレオチド固定化担体
AU681082B2 (en) * 1992-05-06 1997-08-21 Gen-Probe Incorporated Nucleic acid sequence amplification method, composition and kit
CA2140763A1 (en) * 1992-07-28 1994-02-03 Masato Mitsuhashi Gene detection system
US5712127A (en) 1996-04-29 1998-01-27 Genescape Inc. Subtractive amplification
DE19633427C2 (de) * 1996-08-20 2001-10-04 Hubert S Bernauer Verfahren zur Synthese von Nukleinsäuremolekülen mit zumindest teilweise vorbestimmter Nukleotidsequenz
DE19812103A1 (de) * 1998-03-19 1999-09-23 Bernauer Annette Verfahren zur Synthese von Nucleinsäuremolekülen
BRPI0207893B8 (pt) 2001-03-07 2021-07-27 Biomerieux Bv método para a amplificação com base em transcrição de uma seqüência de ácido nucléico do hbv de filamento duplo alvo partindo do dna do hbv opcionalmente presente em uma amostra, oligonucleotídeo, e, conjunto de teste adequado para realizar a amplificação e detecção com base em transcrição de dna do hbv
KR20030088035A (ko) * 2001-03-07 2003-11-15 바이오메리욱스 비.브이. 전사 기초한 증폭을 이용하는 ｄｎａ의 증폭 및 검출 방법
US8137911B2 (en) * 2001-05-22 2012-03-20 Cellscript, Inc. Preparation and use of single-stranded transcription substrates for synthesis of transcription products corresponding to target sequences
WO2004059289A2 (en) * 2001-05-22 2004-07-15 Epicentre Technologies Target-dependent transcription using deletion mutants of n4 rna polymerase
US7504215B2 (en) 2002-07-12 2009-03-17 Affymetrix, Inc. Nucleic acid labeling methods
US20050003369A1 (en) * 2002-10-10 2005-01-06 Affymetrix, Inc. Method for depleting specific nucleic acids from a mixture
EP1576188B1 (de) * 2002-11-21 2008-10-15 Epicentre Technologies Verfahren zur verwendung von riboprimern zur strangverdrängungsreplikation von zielsequenzen
US7266295B2 (en) * 2003-04-17 2007-09-04 Intel Corporation Modular reconfigurable multi-server system and method for high-speed networking within photonic burst-switched network
US7374885B2 (en) * 2004-08-27 2008-05-20 Gen-Probe Incorporated Single-primer nucleic acid amplification methods
US7713697B2 (en) * 2004-08-27 2010-05-11 Gen-Probe Incorporated Methods and kits for amplifying DNA
WO2006122354A1 (en) 2005-05-17 2006-11-23 Ozgene Pty Ltd Sequential cloning system
US8293684B2 (en) * 2006-11-29 2012-10-23 Exiqon Locked nucleic acid reagents for labelling nucleic acids
US8183359B2 (en) * 2007-03-01 2012-05-22 Gen-Probe Incorporated Kits for amplifying DNA
CA2707436C (en) * 2007-06-29 2014-01-28 Epicentre Technologies Corporation Copy dna and sense rna
WO2010126913A1 (en) 2009-04-27 2010-11-04 Gen-Probe Incorporated Methods and kits for use in the selective amplification of target sequences
US9732337B2 (en) 2009-06-16 2017-08-15 The United Stated of America, as represented by the Secretary, Department of Health & Human Services RNA nanoparticles and nanotubes
TWI518325B (zh) 2010-02-04 2016-01-21 自治醫科大學 對ａｌｋ抑制劑具有先抗性或後抗性癌症的識別、判斷和治療
US8822663B2 (en) 2010-08-06 2014-09-02 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
DK4108671T3 (da) 2010-10-01 2025-01-06 Modernatx Inc Modificerede nukleosider, nukleotider og nukleinsyrer samt anvendelser deraf
JP2014511687A (ja) 2011-03-31 2014-05-19 モデルナ セラピューティクス インコーポレイテッド 工学操作された核酸の送達および製剤
US9464124B2 (en) 2011-09-12 2016-10-11 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
JP6113737B2 (ja) 2011-10-03 2017-04-12 モデルナティエックス インコーポレイテッドＭｏｄｅｒｎａＴＸ，Ｉｎｃ． 修飾型のヌクレオシド、ヌクレオチドおよび核酸、ならびにそれらの使用方法
KR20140102759A (ko) 2011-12-16 2014-08-22 모더나 세라퓨틱스, 인코포레이티드 변형된 뉴클레오사이드, 뉴클레오타이드 및 핵산 조성물
FR2984357B1 (fr) 2011-12-16 2016-11-18 Biomerieux Sa Procede d'amplification transcriptionnelle d'acides nucleiques reunissant des etapes de temperatures differentes
US9572897B2 (en) 2012-04-02 2017-02-21 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
US9283287B2 (en) 2012-04-02 2016-03-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of nuclear proteins
EP2834259A4 (de) 2012-04-02 2016-08-24 Moderna Therapeutics Inc Modifizierte polynukleotide
US9254311B2 (en) 2012-04-02 2016-02-09 Moderna Therapeutics, Inc. Modified polynucleotides for the production of proteins
US9597380B2 (en) 2012-11-26 2017-03-21 Modernatx, Inc. Terminally modified RNA
US8980864B2 (en) 2013-03-15 2015-03-17 Moderna Therapeutics, Inc. Compositions and methods of altering cholesterol levels
US10190143B2 (en) 2013-07-08 2019-01-29 The Board Of Regents Of The University Of Texas System Method for synthesizing selectively labeled RNA
ES2857908T3 (es) 2013-08-28 2021-09-29 Becton Dickinson Co Análisis masivamente paralelo de células individuales
WO2015042101A1 (en) 2013-09-17 2015-03-26 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Multifunctional rna nanoparticles and methods of use
US10023626B2 (en) 2013-09-30 2018-07-17 Modernatx, Inc. Polynucleotides encoding immune modulating polypeptides
EP3052521A1 (de) 2013-10-03 2016-08-10 Moderna Therapeutics, Inc. Polynukleotide zur codierung von low-density-lipoprotein-rezeptor
JP2016539639A (ja) 2013-11-13 2016-12-22 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル キッシング複合体を形成することができる核酸を含むキットオブパーツ及びその使用
WO2015171827A1 (en) 2014-05-06 2015-11-12 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Triggering rna interference with rna-dna and dna-rna nanoparticles
WO2018187373A1 (en) 2017-04-03 2018-10-11 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Functionally-interdependent shape switching nucleic acid nanoparticles

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4766072A (en) * 1985-07-17 1988-08-23 Promega Corporation Vectors for in vitro production of RNA copies of either strand of a cloned DNA sequence
IL86724A (en) * 1987-06-19 1995-01-24 Siska Diagnostics Inc Methods and kits for amplification and testing of nucleic acid sequences
EP0359789B1 (de) * 1988-01-21 1993-08-04 Genentech, Inc. Verstärkung und nachweis von nukleinsäuresequenzen
CA1340807C (en) * 1988-02-24 1999-11-02 Lawrence T. Malek Nucleic acid amplification process

Also Published As

Publication number Publication date
AU641159B2 (en) 1993-09-16
AU5487790A (en) 1990-11-15
CA2016358A1 (en) 1990-11-10
DE69016826D1 (de) 1995-03-23
US5466586A (en) 1995-11-14
EP0397269A1 (de) 1990-11-14
DK0397269T3 (da) 1995-05-29
KR900018376A (ko) 1990-12-21
FI902318A0 (fi) 1990-05-09
IE901624L (en) 1990-11-10
CA2016358C (en) 2000-11-28
KR0185376B1 (ko) 1999-04-01
DE69016826T2 (de) 1995-06-08
IE66597B1 (en) 1996-01-24
JP2839639B2 (ja) 1998-12-16
ES2070995T3 (es) 1995-06-16
JPH03180184A (ja) 1991-08-06
EP0397269B1 (de) 1995-02-15
FI102387B (fi) 1998-11-30
ZA903453B (en) 1991-02-27
FI102387B1 (fi) 1998-11-30

Similar Documents

Publication Publication Date Title
ATE118549T1 (de) Verfahren zur synthese von ribonukleinsäure (rns).
DE69937223D1 (de) Verfahren zur synthese von nukleinsäuren
DE3850093D1 (de) Verfahren zur Amplifizierung von Nukleinsäuren.
ATE236269T1 (de) Ein elektrochemiluminescenter nachweis von nukleinsäuren auf basis der selbsttragenden sequenzreplikation
DE69034177D1 (de) Verfahren zur Amplifikation von Nukleinsäuresequenzen
ATE365812T1 (de) Verfahren zur unterscheidung von sequenz varianten
DE59008105D1 (de) Modifiziertes Phosphoramidit-Verfahren zur Herstellung von modifizierten Nukleinsäuren.
NO895090D0 (no) Fremgangsmaate og system for deteksjonsdiagnostisering.
DE69916005D1 (de) Effizientes Verfahren zum Auffinden von Genfunktionen mittels Bibliotheken zur funktionellen Genomanwendung
DE60127162D1 (de) Massives Parallelverfahren zur Dekodierung von DNA und RNA
IL112750A0 (en) Nucleic acid detection kit
DE69837913D1 (de) Verfahren zur vervielfältigung von nukleinsäure
DE68916671D1 (de) Mutationsnachweis durch kompetitiven Oligonukleotid-Priming.
CA2264967A1 (en) Method of dna sequencing
Padmanabhan et al. Chemical synthesis of a primer and its use in the sequence analysis of the lysozyme gene of bacteriophage T4
DE69626032D1 (de) Modifizierung von oligonukleotid-primer-sequenzen zum manipilieren der zugabe von nicht-template-nukleotiden
ATE317123T1 (de) Reaktiver träger zur bestimmung von dna fragmenten
EP1061130A4 (de) Transkriptions-promoteren für rna-polymerase und verfahren zur bestimmung einer basensequenz.
ATE220419T1 (de) Verfahren zur herstellung von cis-3-hydroxy-l- prolin

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time